[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antithrombin (Recombinant) Market Research Report 2024(Status and Outlook)

August 2024 | 96 pages | ID: G08C6ED23554EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

Recombinantantithrombins with properties similar to those of normal human antithrombin have been produced usingbaculovirus-infected insect cells and mammalian cell lines grown incell culture.

This report provides a deep insight into the global Antithrombin (Recombinant) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antithrombin (Recombinant) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antithrombin (Recombinant) market in any manner.

Global Antithrombin (Recombinant) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

LFB Biotechnologies

Market Segmentation (by Type)

Lyophilized Formulation

Lyophilized Powder

Market Segmentation (by Application)

Hospital

Clinic

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Antithrombin (Recombinant) Market
  • Overview of the regional outlook of the Antithrombin (Recombinant) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antithrombin (Recombinant) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Antithrombin (Recombinant)
1.2 Key Market Segments
  1.2.1 Antithrombin (Recombinant) Segment by Type
  1.2.2 Antithrombin (Recombinant) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTITHROMBIN (RECOMBINANT) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Antithrombin (Recombinant) Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Antithrombin (Recombinant) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTITHROMBIN (RECOMBINANT) MARKET COMPETITIVE LANDSCAPE

3.1 Global Antithrombin (Recombinant) Sales by Manufacturers (2019-2024)
3.2 Global Antithrombin (Recombinant) Revenue Market Share by Manufacturers (2019-2024)
3.3 Antithrombin (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antithrombin (Recombinant) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antithrombin (Recombinant) Sales Sites, Area Served, Product Type
3.6 Antithrombin (Recombinant) Market Competitive Situation and Trends
  3.6.1 Antithrombin (Recombinant) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Antithrombin (Recombinant) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ANTITHROMBIN (RECOMBINANT) INDUSTRY CHAIN ANALYSIS

4.1 Antithrombin (Recombinant) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTITHROMBIN (RECOMBINANT) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ANTITHROMBIN (RECOMBINANT) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antithrombin (Recombinant) Sales Market Share by Type (2019-2024)
6.3 Global Antithrombin (Recombinant) Market Size Market Share by Type (2019-2024)
6.4 Global Antithrombin (Recombinant) Price by Type (2019-2024)

7 ANTITHROMBIN (RECOMBINANT) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antithrombin (Recombinant) Market Sales by Application (2019-2024)
7.3 Global Antithrombin (Recombinant) Market Size (M USD) by Application (2019-2024)
7.4 Global Antithrombin (Recombinant) Sales Growth Rate by Application (2019-2024)

8 ANTITHROMBIN (RECOMBINANT) MARKET SEGMENTATION BY REGION

8.1 Global Antithrombin (Recombinant) Sales by Region
  8.1.1 Global Antithrombin (Recombinant) Sales by Region
  8.1.2 Global Antithrombin (Recombinant) Sales Market Share by Region
8.2 North America
  8.2.1 North America Antithrombin (Recombinant) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Antithrombin (Recombinant) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Antithrombin (Recombinant) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Antithrombin (Recombinant) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Antithrombin (Recombinant) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 LFB Biotechnologies
  9.1.1 LFB Biotechnologies Antithrombin (Recombinant) Basic Information
  9.1.2 LFB Biotechnologies Antithrombin (Recombinant) Product Overview
  9.1.3 LFB Biotechnologies Antithrombin (Recombinant) Product Market Performance
  9.1.4 LFB Biotechnologies Business Overview
  9.1.5 LFB Biotechnologies Antithrombin (Recombinant) SWOT Analysis
  9.1.6 LFB Biotechnologies Recent Developments

10 ANTITHROMBIN (RECOMBINANT) MARKET FORECAST BY REGION

10.1 Global Antithrombin (Recombinant) Market Size Forecast
10.2 Global Antithrombin (Recombinant) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Antithrombin (Recombinant) Market Size Forecast by Country
  10.2.3 Asia Pacific Antithrombin (Recombinant) Market Size Forecast by Region
  10.2.4 South America Antithrombin (Recombinant) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Antithrombin (Recombinant) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Antithrombin (Recombinant) Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Antithrombin (Recombinant) by Type (2025-2030)
  11.1.2 Global Antithrombin (Recombinant) Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Antithrombin (Recombinant) by Type (2025-2030)
11.2 Global Antithrombin (Recombinant) Market Forecast by Application (2025-2030)
  11.2.1 Global Antithrombin (Recombinant) Sales (Kilotons) Forecast by Application
  11.2.2 Global Antithrombin (Recombinant) Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antithrombin (Recombinant) Market Size Comparison by Region (M USD)
Table 5. Global Antithrombin (Recombinant) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antithrombin (Recombinant) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antithrombin (Recombinant) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antithrombin (Recombinant) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin (Recombinant) as of 2022)
Table 10. Global Market Antithrombin (Recombinant) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antithrombin (Recombinant) Sales Sites and Area Served
Table 12. Manufacturers Antithrombin (Recombinant) Product Type
Table 13. Global Antithrombin (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antithrombin (Recombinant)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antithrombin (Recombinant) Market Challenges
Table 22. Global Antithrombin (Recombinant) Sales by Type (Kilotons)
Table 23. Global Antithrombin (Recombinant) Market Size by Type (M USD)
Table 24. Global Antithrombin (Recombinant) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antithrombin (Recombinant) Sales Market Share by Type (2019-2024)
Table 26. Global Antithrombin (Recombinant) Market Size (M USD) by Type (2019-2024)
Table 27. Global Antithrombin (Recombinant) Market Size Share by Type (2019-2024)
Table 28. Global Antithrombin (Recombinant) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antithrombin (Recombinant) Sales (Kilotons) by Application
Table 30. Global Antithrombin (Recombinant) Market Size by Application
Table 31. Global Antithrombin (Recombinant) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antithrombin (Recombinant) Sales Market Share by Application (2019-2024)
Table 33. Global Antithrombin (Recombinant) Sales by Application (2019-2024) & (M USD)
Table 34. Global Antithrombin (Recombinant) Market Share by Application (2019-2024)
Table 35. Global Antithrombin (Recombinant) Sales Growth Rate by Application (2019-2024)
Table 36. Global Antithrombin (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antithrombin (Recombinant) Sales Market Share by Region (2019-2024)
Table 38. North America Antithrombin (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antithrombin (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antithrombin (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antithrombin (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antithrombin (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 43. LFB Biotechnologies Antithrombin (Recombinant) Basic Information
Table 44. LFB Biotechnologies Antithrombin (Recombinant) Product Overview
Table 45. LFB Biotechnologies Antithrombin (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. LFB Biotechnologies Business Overview
Table 47. LFB Biotechnologies Antithrombin (Recombinant) SWOT Analysis
Table 48. LFB Biotechnologies Recent Developments
Table 49. Global Antithrombin (Recombinant) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Antithrombin (Recombinant) Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Antithrombin (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Antithrombin (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Antithrombin (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Antithrombin (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Antithrombin (Recombinant) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Antithrombin (Recombinant) Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Antithrombin (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Antithrombin (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Antithrombin (Recombinant) Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Antithrombin (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Antithrombin (Recombinant) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Antithrombin (Recombinant) Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Antithrombin (Recombinant) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Antithrombin (Recombinant) Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Antithrombin (Recombinant) Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Antithrombin (Recombinant)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antithrombin (Recombinant) Market Size (M USD), 2019-2030
Figure 5. Global Antithrombin (Recombinant) Market Size (M USD) (2019-2030)
Figure 6. Global Antithrombin (Recombinant) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antithrombin (Recombinant) Market Size by Country (M USD)
Figure 11. Antithrombin (Recombinant) Sales Share by Manufacturers in 2023
Figure 12. Global Antithrombin (Recombinant) Revenue Share by Manufacturers in 2023
Figure 13. Antithrombin (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antithrombin (Recombinant) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antithrombin (Recombinant) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antithrombin (Recombinant) Market Share by Type
Figure 18. Sales Market Share of Antithrombin (Recombinant) by Type (2019-2024)
Figure 19. Sales Market Share of Antithrombin (Recombinant) by Type in 2023
Figure 20. Market Size Share of Antithrombin (Recombinant) by Type (2019-2024)
Figure 21. Market Size Market Share of Antithrombin (Recombinant) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antithrombin (Recombinant) Market Share by Application
Figure 24. Global Antithrombin (Recombinant) Sales Market Share by Application (2019-2024)
Figure 25. Global Antithrombin (Recombinant) Sales Market Share by Application in 2023
Figure 26. Global Antithrombin (Recombinant) Market Share by Application (2019-2024)
Figure 27. Global Antithrombin (Recombinant) Market Share by Application in 2023
Figure 28. Global Antithrombin (Recombinant) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antithrombin (Recombinant) Sales Market Share by Region (2019-2024)
Figure 30. North America Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antithrombin (Recombinant) Sales Market Share by Country in 2023
Figure 32. U.S. Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antithrombin (Recombinant) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antithrombin (Recombinant) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antithrombin (Recombinant) Sales Market Share by Country in 2023
Figure 37. Germany Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antithrombin (Recombinant) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antithrombin (Recombinant) Sales Market Share by Region in 2023
Figure 44. China Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antithrombin (Recombinant) Sales and Growth Rate (Kilotons)
Figure 50. South America Antithrombin (Recombinant) Sales Market Share by Country in 2023
Figure 51. Brazil Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antithrombin (Recombinant) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antithrombin (Recombinant) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antithrombin (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antithrombin (Recombinant) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antithrombin (Recombinant) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antithrombin (Recombinant) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antithrombin (Recombinant) Market Share Forecast by Type (2025-2030)
Figure 65. Global Antithrombin (Recombinant) Sales Forecast by Application (2025-2030)
Figure 66. Global Antithrombin (Recombinant) Market Share Forecast by Application (2025-2030)


More Publications